Evidence map›Paper›PMID 35730618›Full record

ArticleOncology reports2022

Weixiao An, Yuxi Zhang, Honglin Lai, Yangyang Zhang, Hongmei Zhang, Ge Zhao, Minghua Liu, Yang Li, Xiukun Lin, Shousong Cao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Weixiao An *Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Yuxi Zhang *Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Honglin LaiDepartment of Pharmacy, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Yangyang ZhangDepartment of Pharmacy, Dongying Hospital of Traditional Chinese Medicine, Dongying, Shandong 257055, P.R. China.
Hongmei ZhangRizhao Hospital of Traditional Chinese Medicine, Rizhao, Shandong 276801, P.R. China.
Ge ZhaoDepartment of Pharmacology, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China.
Minghua LiuDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Yang LiDepartment of International Trade, School of International Traded and Economics, University of International Business and Economics, Beijing 100029, P.R. China.
Xiukun LinDelisi Group Co. Ltd., Zhucheng, Shandong 262200, P.R. China.
Shousong CaoDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Southwest Medical University · CNChengdu University of Traditional Chinese Medicine · CNDongyang People's Hospital · CNPeople’s Hospital of Rizhao · CNUniversity of International Business and Economics · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlpiniaLung NeoplasmsAMP-Activated Protein KinasesAnimalsApoptosisAutophagyCaspase 3Caspase 8Caspase 9Cell Line, TumorHumansMiceMice, NudePoly(ADP-ribose) Polymerase InhibitorsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaAMP-Activated Protein KinasesCaspase 3Caspase 8Caspase 9MTOR protein, humanPoly(ADP-ribose) Polymerase InhibitorsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaTOR Serine-Threonine Kinasesadenosine 5'‑monophosphate‑activated protein kinaseAlpinia katsumadai Hayataapoptosisautophagyserine‑­threonine kinase/mammalian target of rapamycin/70‑kDa ribosomal protein S6 kinase signaling pathway

Identifiers

PMID35730618
PMCPMC9245070
OpenAlexW4283165790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.